Disc Medicine, Inc
Clinical trials sponsored by Disc Medicine, Inc, explained in plain language.
-
New drug could let Sun-Sensitive patients enjoy the outdoors Pain-Free
Disease control OngoingThis study tests whether the drug bitopertin can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will receive either bitopertin or a placebo for 6 months. Rese…
Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New hope for sunlight pain: bitopertin Long-Term trial opens
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called bitopertin over the long term in people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain when skin is exposed to sunlight. About 230 participants who completed a prior bitopertin study…
Phase: PHASE2, PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 18, 2026 12:06 UTC